GC
IOVA icon

Guggenheim Capital’s Iovance Biotherapeutics IOVA Stock Holding History

Guggenheim Capital’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-110,380
Closed -$240K – 1798
2025
Q3 		$240K Sell
110,380
-12,487
-10% -$29.5K ﹤0.01% 1467
2025
Q2 		$211K Sell
122,867
-25,483
-17% -$63.4K ﹤0.01% 1495
2025
Q1 		$494K Buy
148,350
+49,410
+50% +$255K ﹤0.01% 1208
2024
Q4 		$732K Sell
98,940
-10,880
-10% -$101K 0.01% 1074
2024
Q3 		$1.03M Sell
109,820
-2,651
-2% -$25.1K 0.01% 1087
2024
Q2 		$902K Buy
112,471
+35,008
+45% +$375K 0.01% 1177
2024
Q1 		$1.15M Sell
77,463
-31,638
-29% -$368K 0.01% 1121
2023
Q4 		$887K Buy
+109,101
New +$571K 0.01% 1212
2023
Q1 		– Sell
-111,286
Closed -$711K – 1963
2022
Q4 		$711K Sell
111,286
-564
-0.5% -$4.4K 0.01% 1331
2022
Q3 		$1.07M Sell
111,850
-16,701
-13% -$193K 0.01% 1112
2022
Q2 		$1.42M Buy
128,551
+15,438
+14% +$202K 0.01% 1059
2022
Q1 		$1.88M Buy
113,113
+8,517
+8% +$132K 0.01% 1052
2021
Q4 		$2M Buy
104,596
+9,297
+10% +$205K 0.01% 1057
2021
Q3 		$2.35M Sell
95,299
-2,761
-3% -$65.1K 0.01% 976
2021
Q2 		$2.55M Buy
98,060
+8,638
+10% +$225K 0.02% 959
2021
Q1 		$2.83M Buy
89,422
+20,024
+29% +$830K 0.02% 856
2020
Q4 		$3.22M Sell
69,398
-13,243
-16% -$526K 0.02% 764
2020
Q3 		$2.72M Sell
82,641
-29,961
-27% -$919K 0.02% 762
2020
Q2 		$3.09M Buy
+112,602
New +$3.7M 0.02% 707

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Guggenheim Capital's IOVA Position: Q4 2025 in Review

Guggenheim Capital sold out of Iovance Biotherapeutics (IOVA) in Q4 2025, closing a stake of 110,380 shares — an estimated $240K sold.

Guggenheim Capital first reported a position in IOVA in Q2 2020 and held it in 19 quarters. The position peaked at $3.22M in Q4 2020. 263 funds tracked by Wall St. Rank hold IOVA as of Q4 2025.

  • Guggenheim Capital reported no remaining Iovance Biotherapeutics position as of Q4 2025 after selling out during the quarter.
  • Guggenheim Capital sold 110,380 Iovance Biotherapeutics shares in Q4 2025, an estimated $240K.
  • Guggenheim Capital first reported a position in Iovance Biotherapeutics in Q2 2020 and held it in 19 quarters.
  • Guggenheim Capital's Iovance Biotherapeutics position peaked at $3.22M in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2025.

Based on Guggenheim Capital's 13F filing for Q4 2025, filed 17 Feb 2026.